Market Place
Sourcing Support
cGMP Non-Compliance Recap 2020
The coronavirus pandemic changed the way we lived our lives, and
regulatory agencies were no except
New Drugs Approvals by FDA and EMA: 2020 Recap
The year
2020 was an eventful year for the pharmaceutical industry, with several
companies across
Covid-19 HCQ update: Studies in France, Brazil, China raise more questions on its efficacy, safety
Last month, we had carried an article ‘Hydroxychloroquine: Hype versus reality’ that
hi
Chinese industrial activity revival at 98.6 percent, officials assure of API supplies
While the world feels the heat of the Covid-19 pandemic with the global pharmaceutical supply chain
Hydroxychloroquine: Hype versus reality
The
President of United States Donald Trump’s
tweet
late last week has swung the pharmaceut
Investors up ante against Mylan board; More Ipca products banned from the US
This week, Phispers looks at fresh troubles brewing at Mylan, as rebel investors intensify their dem
